Aberrant expression of T-cell immunoglobulin domain and mucin domain 4 (TIM-4) correlates with poor LC prognosis, and IL-6 can upregulate TIM-4 via NF-κB activation, promoting EMT expression and LC development (156). The gene discussed is TIMD4; the disease is laryngotracheoesophageal cleft.